NO20024576D0 - Fremgangsmåter for å inhibere angiogenese og tumorvekst - Google Patents

Fremgangsmåter for å inhibere angiogenese og tumorvekst

Info

Publication number
NO20024576D0
NO20024576D0 NO20024576A NO20024576A NO20024576D0 NO 20024576 D0 NO20024576 D0 NO 20024576D0 NO 20024576 A NO20024576 A NO 20024576A NO 20024576 A NO20024576 A NO 20024576A NO 20024576 D0 NO20024576 D0 NO 20024576D0
Authority
NO
Norway
Prior art keywords
methods
tumor growth
inhibit angiogenesis
angiogenesis
inhibit
Prior art date
Application number
NO20024576A
Other languages
English (en)
Other versions
NO20024576L (no
Inventor
Dale L Boger
David A Cheresh
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20024576D0 publication Critical patent/NO20024576D0/no
Publication of NO20024576L publication Critical patent/NO20024576L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20024576A 2000-03-27 2002-09-24 Fremgangsmate for a inhibere angiogenese og tumorvekst NO20024576L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27
PCT/US2001/009785 WO2001072297A1 (en) 2000-03-27 2001-03-27 Methods for inhibiting angiogenesis and tumor growth

Publications (2)

Publication Number Publication Date
NO20024576D0 true NO20024576D0 (no) 2002-09-24
NO20024576L NO20024576L (no) 2002-11-20

Family

ID=22708924

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20024578A NO328969B1 (no) 2000-03-27 2002-09-24 Forbindelser, sammensetninger og anvendelser derav
NO20024576A NO20024576L (no) 2000-03-27 2002-09-24 Fremgangsmate for a inhibere angiogenese og tumorvekst

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20024578A NO328969B1 (no) 2000-03-27 2002-09-24 Forbindelser, sammensetninger og anvendelser derav

Country Status (15)

Country Link
EP (2) EP1276713A4 (no)
JP (2) JP2003528850A (no)
KR (2) KR100767616B1 (no)
CN (2) CN1229339C (no)
AU (4) AU5101801A (no)
CA (3) CA2659030A1 (no)
CZ (2) CZ20023510A3 (no)
HU (2) HUP0301797A3 (no)
MX (2) MXPA02009510A (no)
NO (2) NO328969B1 (no)
PL (2) PL358272A1 (no)
RU (2) RU2276133C2 (no)
SK (2) SK14852002A3 (no)
WO (2) WO2001072297A1 (no)
ZA (2) ZA200208626B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2315721T5 (es) 2003-10-23 2012-08-24 Otsuka Pharmaceutical Co., Ltd. Formulación de aripiprazol inyectable estéril de liberación controlada y procedimiento
LT2170279T (lt) 2007-07-31 2018-03-12 Otsuka Pharmaceutical Co., Ltd. Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US6294674B1 (en) * 1996-09-04 2001-09-25 Warner-Lambert Company Dibenzofuran sulfonamide matrix metalloproteinase inhibitors
CA2279869A1 (en) * 1997-02-07 1998-08-13 Dale L. Boger Convergent synthesis of combinatorial library
EP1063982B1 (en) * 1998-03-27 2007-02-14 Genentech, Inc. Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders

Also Published As

Publication number Publication date
KR100776185B1 (ko) 2007-11-16
WO2001072297A1 (en) 2001-10-04
EP1272173A1 (en) 2003-01-08
RU2269339C2 (ru) 2006-02-10
EP1276713A1 (en) 2003-01-22
CN1245967C (zh) 2006-03-22
NO328969B1 (no) 2010-06-28
MXPA02009510A (es) 2003-05-21
CN1429106A (zh) 2003-07-09
PL358272A1 (en) 2004-08-09
CA2403871C (en) 2010-05-11
KR100767616B1 (ko) 2007-10-18
PL366316A1 (en) 2005-01-24
HUP0301621A2 (hu) 2003-09-29
JP2003528140A (ja) 2003-09-24
CN1229339C (zh) 2005-11-30
WO2001072699A1 (en) 2001-10-04
CZ20023509A3 (cs) 2003-06-18
ZA200208628B (en) 2004-02-12
CA2403630A1 (en) 2001-10-04
AU4949901A (en) 2001-10-08
CZ20023510A3 (cs) 2003-03-12
KR20020091156A (ko) 2002-12-05
SK14842002A3 (sk) 2003-04-01
SK14852002A3 (sk) 2003-06-03
AU2001249499B2 (en) 2005-04-21
HUP0301621A3 (en) 2009-06-29
ZA200208626B (en) 2004-02-16
EP1276713A4 (en) 2006-05-03
AU5101801A (en) 2001-10-08
JP2003528850A (ja) 2003-09-30
HUP0301797A3 (en) 2010-09-28
NO20024578D0 (no) 2002-09-24
EP1272173A4 (en) 2006-05-03
CA2403630C (en) 2009-05-26
PL205134B1 (pl) 2010-03-31
AU2001251018B2 (en) 2005-12-01
CN1441777A (zh) 2003-09-10
MXPA02009504A (es) 2003-05-21
KR20020084258A (ko) 2002-11-04
RU2276133C2 (ru) 2006-05-10
NO20024578L (no) 2002-11-20
HUP0301797A2 (hu) 2003-09-29
CA2403871A1 (en) 2001-10-04
RU2002128751A (ru) 2004-03-10
NO20024576L (no) 2002-11-20
CA2659030A1 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
NO20023639L (no) Fremgangsmåte og anordninger for å klargjöre brönner
FR2810062B1 (fr) Serre horticole debachable
NO20013926D0 (no) Undersjoisk intervensjon
FI20001055A (fi) Avoauto
DK1344773T3 (da) Væksthormonsekretionsfremmere
DK1333853T3 (da) Vækstfaktorkompleks
NO20016156D0 (no) Dipol/monopol akustisk transmitter og fremgangsmåte for å anvende denne i nedihullsverktöy
ZA200106197B (en) Use of glycogen phosphorlase inhibitors to inhibit tumor growth.
DE60019900D1 (de) Tragbares Bett
NO20015764D0 (no) Fremgangsmåte og blanding for å maskere mineralsmak
DE50008926D1 (de) Matratze
NO20022057D0 (no) Fremgangsmåte og sammensetning for å behandle lungesykdommer
NO20024576D0 (no) Fremgangsmåter for å inhibere angiogenese og tumorvekst
NO20030593D0 (no) Fremgangsmåter for behandling av cancer og smerten forbundet derved ved å anvende endotelinantagonister
NO20032623L (no) Filtpappstruktur og fremgangsmåte for å produsere trykkfilt
ID30377A (id) Metoda pengobatan neurodegenerasi
NO20034617L (no) Fremgangsmåter for å inhibere viral replikasjon
FR2788195B1 (fr) Serre tunnel
GB0003799D0 (en) Improvements to bedding
FR2804849B1 (fr) Canape lit convertible
TW465274U (en) V-type water cultivation bed structure
GB9912249D0 (en) Horticultural string and wire carry kit
TW498715U (en) Improved structure of flowerpot
FIU20000326U0 (fi) Muistokivi
UA4004S (uk) Шпала

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application